Raising the Bar: Updates In Organ Transplantation for People with HIV/AIDS

Sapna A. Mehta, MD, FIDSA
Director, Transplant Infectious Diseases
Clinical Director, NYU Langone Transplant Institute
Associate Professor of Medicine, NYU Grossman School of Medicine

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Sapna Mehta is the Director of Transplant Infectious Diseases and the Clinical Director of the NYU Langone Transplant Institute and Associate Professor of Medicine at NYU Grossman School of Medicine. Dr. Mehta received her MD from Baylor College of Medicine in 2003 where she also completed her Internal Medicine residency. She completed her infectious diseases fellowship at NYU in 2009. Her clinical experience in HIV medicine has included HIV primary care, implementation of HIV care protocols under an NYU partner PEPFAR site in Kenya, and over the last decade providing care for transplant patients with HIV infection. Dr. Mehta has a particular interest in improving awareness around transplant options for people living with HIV in the New York region. She is NYU’s site investigator for the multi-center HOPE clinical trials through which HIV positive transplant recipients can receive organs from HIV positive donors. Dr. Mehta has also developed NYU’s living kidney donor program for HIV-positive donors. She is currently the Chair of the HIV Working Group of the American Society of Transplantation's Infectious Diseases Community of Practice.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Understand the ongoing need for transplantation and current transplantation options among people living with HIV in the United States.
2. Be aware of clinical outcomes of HIV-positive organ use for HIV-positive recipients.
3. Appreciate the early experience to date with living donor kidney transplantation from HIV-positive donors for HIV-positive recipients.
4. Learn about how the HOPE act has impacted access to organ transplantation for people living with HIV/AIDS.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for June 18, 2024, as a live activity. This activity will also be available as an enduring activity from June 25, 2024, through June 17, 2027.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Krisczar J. Bungay (Moderator) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Speaker for Gilead, ViiV, Merck, Janssen and Idorsia. All relevant financial relationships have been mitigated.
- Dr. Sapna A. Mehta (Presenter) has no relevant financial relationships to disclose. Dr. Mehta submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.

You must be logged in to post a comment. Login | Register